← Eichor
Condition: Malaria Vaccines Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Malaria Vaccines

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Field Trial of PfSPZ-LARC2 Vaccine in Burkinabe Adults
Phase 2 · 1 location(s) · Sanaria Inc. · NCT07385287PfSPZ-LARC2 Vaccine in Women of Child-bearing Potential (WOCBP) in Mali
Phase 2 · 1 location(s) · Sanaria Inc. · NCT07675785Mass Vaccine and Drug Administration, Bangladesh
Phase 4 · 2 location(s) · University of Oxford · NCT06068530A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria V
Phase 1 · 1 location(s) · University of Oxford · NCT06958198Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naïve Adults
Phase 1 · 1 location(s) · Sanaria Inc. · NCT06862453Effectiveness of Malaria Vaccines in Reducing the Risk of Invasive Non-typhoidal Salmonella Disease
Phase N/A · 1 location(s) · International Vaccine Institute · NCT07416461Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria Vaccine
Phase N/A · 4 location(s) · Kintampo Health Research Centre, Ghana · NCT05041556Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Transmission in
Phase 4 · 1 location(s) · Epicentre · NCT07038837Infant Malaria Vaccine Schedule Optimization
Phase 2 · 2 location(s) · PATH · NCT06879327Seasonal R21 Mass Vaccination for Malaria Elimination
Phase 3 · 2 location(s) · London School of Hygiene and Tropical Medicine · NCT06578572A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months
Phase 2 · 2 location(s) · GlaxoSmithKline · NCT07036159Testing a Biometric Identification System to Improve Malaria Vaccine Completion
NA · 1 location(s) · University of Michigan · NCT07261280Dose Finding Trial of R21/Matrix-M in School Children
Phase 2 · 1 location(s) · University of Oxford · NCT07074665Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria C
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT02639299A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.
Phase 1/Phase 2 · 1 location(s) · University of Oxford · NCT05790889Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT02471378An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine
Phase N/A · 5 location(s) · Serum Institute of India Pvt. Ltd. · NCT07009847Integrating Malaria Vaccine With Seasonal Malaria Chemoprevention in West Africa
Phase 4 · 2 location(s) · Epicentre · NCT06860178
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.